ComGen
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $16M
Investors
- 4
About ComGen
Based in Shanghai, China, and established in 2017, ComGen a R&D of drug company that drugs used for treatment for autoimmune diseases and tumors. The company established by professor Mr.,Ltd., and self-complement technology platform. In 2021, it's new drug of new target complement inhibitors has obtained clinical license. Moreover, it has more than 10 drugs been developing, which used in treatment for tumors, autoimmune diseases, rare diseases. The company plans to do first phase clinical trials of new drug of new target complement inhibitors, and advance the progress of other drugs. Moreover, it will continue to develop new drugs, based on the R&D drug platform of complement system.
Who invested in ComGen
4 investors across 1 round
See all investors in ComGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 18, 2021
Amount
$16M
Investors
Questions about ComGen
Who invested in ComGen?
ComGen has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ComGen raised?
ComGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ComGen last raise money?
ComGen's most recent round on record is a Series A, in Nov 2021.
What does ComGen do?
Based in Shanghai, China, and established in 2017, ComGen a R&D of drug company that drugs used for treatment for autoimmune diseases and tumors.
Where is ComGen headquartered?
ComGen is headquartered in Shanghai, China.
Which VCs invest in companies like ComGen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ComGen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like ComGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.